Infections in patients with inflammatory bowel disease.

CONCLUSIONS: Clinical trials have demonstrated that the combined use of immunomodulating agents may increase the risk of new infections. The infections might be intensified by an insufficient vaccination of adults with IBD. Physicians have to be aware of these risks and try to attenuate and treat them properly. KEY WORDS: Infections, Inflammatory bowel disease, Risk factors. PMID: 33554939 [PubMed - in process]
Source: Annali Italiani di Chirurgia - Category: Surgery Tags: Ann Ital Chir Source Type: research